This is supported by other findings showing that siRNA knockdown of α-synuclein induced a significant 50% decrease of DAT activity in neuroblastoma cells [51] like the knock out of α-synuclein significantly decreases striatal DAT expression [18] and DA uptake. The gene discussed is SLC6A3; the disease is neuroblastoma.